Ładuje się......
Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors
AIM: Aberrant c-Met activation plays a critical role in cancer formation, progression and dissemination, as well as in development of resistance to anticancer drugs. Therefore, c-Met has emerged as an attractive target for cancer therapy. The aim of this study was to develop new c-Met inhibitors and...
Zapisane w:
| Wydane w: | Acta Pharmacol Sin |
|---|---|
| Główni autorzy: | , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group
2016
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857548/ https://ncbi.nlm.nih.gov/pubmed/27041462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2016.11 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|